INS and polycystic ovary syndrome: The effects of myoinositol in obese/overweight patients with PCOS has been further compared to those of metformin, showing no differences between the two treatments on body composition, hormone profile, glucose, insulin metabolism, and adiponectin levels in PCOS patients [96].